Latest Industry Press Releases More...

Our portal’s perpetual and fresh feed of latest happenings in the Pharmaceutical Industry is presented through the Press Releases section, which help our clients to gain a good sense of the current trade environment. This information is instrumental for future strategies.

Press Releases

Hutchison China MediTech Limited today announces that it has initiated a Phase II study of sulfatinib in second-line biliary tract cancer (“BTC”) patients in China. Sulfatinib is an oral, novel angio-immunokinase inhibitor that selectively targets vascular endothelial growth factor receptor (“VEGFR”), fibroblast growth factor receptor (“FGFR”) and colony-stimulating factor-1 receptor…

Press Releases

Rigel Pharmaceuticals today announced that on January 3, 2017 and January 16, 2017 the Compensation Committee of Rigel's Board of Directors approved the grant of inducement stock options to purchase an aggregate of 214,000 shares of common stock to four new employees. These awards were granted pursuant to the Rigel…

Press Releases

Braeburn Pharmaceuticals, Inc. today announced that the Centers for Medicare & Medicaid Services (CMS) has granted a Healthcare Common Procedure Coding System (HCPCS) code, or permanent J-code, for Probuphine, the first and only six-month buprenorphine implant for the maintenance treatment of opioid addiction. The new J-code (J0570) became effective January…

Press Releases

MorphoSys AG announced today that its partner Novartis will conduct a phase 2 clinical trial of the HuCAL antibody bimagrumab in obese patients with type 2 diabetes. According to information published on clinicaltrials.gov, the randomized, subject- and investigator-blinded study will enroll 60 obese adult patients with type 2 diabetes to…

Press Releases

Research and Markets has announced the addition of the "Drug And Gene Delivery Devices Market Analysis By Drug Delivery Type, By Gene Delivery Vector, By Gene Delivery Type And Segment Forecasts, 2014 - 2025" report to their offering. The global drug and gene delivery systems market is expected to reach…

Press Releases

Vertex Pharmaceuticals Incorporated announced that it has entered into a licensing agreement with Merck KGaA, Darmstadt, Germany for the worldwide development and commercialization of four promising research and development programs that represent novel approaches to the treatment of cancer. As part of the agreement, Merck KGaA, Darmstadt, Germany will license…

Press Releases

Starpharma Holdings Ltd announced it has been granted Qualified Infectious Disease Product (QIDP) and Fast Track designation for VivaGel® BV by the US Food and Drug Administration (FDA). QIDP and Fast Track designations were granted independently for both the VivaGel® BV treatment and prevention indications for bacterial vaginosis (BV). This…

Press Releases

Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will discuss and network over 40 presentations and case studies focusing on the key issues in large molecule and small molecule drug formulation and drug delivery See Agenda with speakers & presentations. Meet thought-leaders working…

Press Releases

“The FNIH Biomarkers Consortium Inflammation and Immunity Steering Committee Projects and Initiatives” 16th January 2017 | 2pm GMT The FNIH Biomarkers Consortium’s aim is to discover, develop and seek regulatory approval for biomarkers to support and accelerate the development of new drugs, preventive medicine and medical diagnostics. It addresses a…

Press Releases

IACTA Pharmaceuticals, Inc., a privately held pharmaceutical company, has acquired the North American rights to develop and commercialize NM133, an investigational medicine designed to help treat dry eye, from its developer, Nanomerics, Ltd. Nanomerics is a privately held, UK-based, research-stage company with a proprietary Molecular Envelope Technology (MET) licensed from…

loader